Perrigo Company PRGO Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Infant Formula | $89.7M+2.2% | —— | —— | —— | $87.8M— | |
| Self Care | $543.3M-11.6% | —— | —— | —— | $614.3M— | |
| Specialty Care | $207M+4.0% | —— | —— | —— | $199.1M— | |
| Net Sales by Product | ||||||
| Digestive Health | $96.6M-14.4% | $134M-7.7% | $116.1M-5.2% | $119.6M-11.1% | $112.9M-14.3% | |
| Healthy Lifestyle | $142.7M-9.1% | $146.2M+7.4% | $130.3M-2.8% | $134.4M+6.2% | $157M+15.5% | |
| Pain & Sleep | $106.6M-17.8% | —— | —— | —— | $129.7M— | |
| Skin Health | $151.9M+1.5% | —— | —— | —— | $149.6M— | |
| Upper Respiratory | $197.4M-8.1% | $217.8M+5.5% | $209.8M+1.4% | $178.7M+5.4% | $214.7M+7.7% | |
| Women's Health | $55.1M+11.3% | $59.9M+18.1% | $48.9M-2.6% | $59.8M+11.4% | $49.5M-16.4% | |
| Net Sales by Geography | ||||||
| All other countries | $23.4M+4.9% | $26.6M-1.5% | $24M-27.9% | $23.7M-19.1% | $22.3M-25.9% | |
| Europe | $391.4M-5.1% | $398.4M+5.1% | $384M-3.3% | $421.7M+3.3% | $412.3M-1.8% | |
| Ireland | $4.1M-62.7% | $12.7M-0.8% | $8.6M-22.5% | $9.8M-14.0% | $11M+156% | |
| U.S. | $554.4M-9.0% | $684.6M-6.5% | $635.3M-3.3% | $610.9M-2.7% | $609.3M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Perrigo Company break its business down?
- Perrigo Company (PRGO) reports net sales by business across 3 parts — Infant Formula, Self Care and Specialty Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Perrigo Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Perrigo Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
